Division of Medicinal Chemistry Abstracts-235th ACS National ...
Division of Medicinal Chemistry Abstracts-235th ACS National ...
Division of Medicinal Chemistry Abstracts-235th ACS National ...
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
MEDI 32<br />
Synthesis <strong>of</strong> novel triazole-bearing nitroimidazoles with improved antimicrobial activity<br />
against the protozoan pathogen Giardia<br />
Carlos A. Valdez 1 , Jaroslaw Kalisiak 1 , Jonathan C. Tripp 1 , Barbara Davids 2 , Frances Gillin 2 ,<br />
Valery V. Fokin 1 , K. Barry Sharpless 1 , and Lars Eckmann 2 . (1) Department <strong>of</strong> <strong>Chemistry</strong>, The<br />
Scripps Research Institute, 10550 North Torrey Pines Rd., La Jolla, CA 92037, (2) Department<br />
<strong>of</strong> Pathology and Medicine, University <strong>of</strong> California, San Diego, La Jolla, CA 92093<br />
The protozoan enteric parasite, Giardia lamblia, infects hundred <strong>of</strong> millions in the world and is a<br />
major cause <strong>of</strong> waterborne diarrheal disease. The infection is primarily treated with<br />
metronidazole (Mz), a compound belonging to a class known as the 5-nitroimidazole antibiotics.<br />
Standard treatment with Mz is safe and effective in 80-90% <strong>of</strong> cases, but treatment failure is<br />
common and Mz-resistant strains <strong>of</strong> the parasite have been reported. To overcome resistance,<br />
new and more potent antigiardial drugs are in needed. Herein, we describe the use <strong>of</strong> click<br />
chemistry, more specifically the copper(I)-catalyzed azide-alkyne cycloaddition reaction, to<br />
rapidly and efficiently generate a library <strong>of</strong> triazole-bearing 5-nitroimidazoles for use against the<br />
parasite and its resistant variants. The synthesis and biological evaluation <strong>of</strong> a number <strong>of</strong> novel<br />
5-nitroimidazolides will be presented.<br />
MEDI 33<br />
Synthesis and biological activity <strong>of</strong> antagonists <strong>of</strong> AI-2-mediated bacterial quorum<br />
sensing in Vibrio harveyi<br />
Yunfeng Cheng 1 , Nanting Ni 1 , Minyong Li 1 , Han-Ting Chou 2 , Chung-dar Lu 2 , Phang C Tai 2 , and<br />
Binghe Wang 1 . (1) Department <strong>of</strong> <strong>Chemistry</strong>, Georgia State University, 50 Decatur Street,<br />
Atlanta, GA 30303, jerry_cyf@hotmail.com, (2) Biology Center for Biotechnology and Drug<br />
Design, Georgia State University, Atlanta, GA 30303<br />
Bacterial quorum sensing is a process <strong>of</strong> community-wide regulation <strong>of</strong> behaviors through the<br />
secretion and sensing <strong>of</strong> chemical autoinducers (AI). Because quorum sensing is implicated in<br />
pathologically relevant bacterial traits such as bi<strong>of</strong>ilm formation, conjugation, virulence factor<br />
production, and drug resistance, we are interested in developing quorum sensing inhibitors as<br />
potential therapeutic agents. In this effort, we conducted virtual screening against the<br />
audoinducer-2 (AI-2) receptor protein in Vibrio harveyi, LuxP. Among the 26 candidates<br />
selected for evaluation <strong>of</strong> their ability to inhibit AI-2 mediated quorum sensing, several showed<br />
good inhibitory activities in a bioluminescence assay (IC50: 40-50 micromolar). From these<br />
promising hits, 12 analogs were designed, synthesized, and evaluated. Several synthetic<br />
analogs showed improved activities. This presentation will discuss the design, synthesis, and<br />
structure-activity relationship studies <strong>of</strong> these AI-2 inhibitors.